Ihor Marakhovskyi
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Ihor Marakhovskyi has a total of 58 co-authors. Here are the top co-authors by number of shared publications:
- Inna Bielkina
SI «V. Danilevsky Institute for Endocrine pathology Problems of the NAMS of Ukraine», Kharkiv, Ukraine
10 shared publications - Volodymyr Bondarenko
SI «V. Danilevsky Institute for Endocrine pathology Problems of the NAMS of Ukraine», Kharkiv, Ukraine
10 shared publications - Yevheniia Korenieva
SI «V. Danilevsky Institute for Endocrine pathology Problems of the NAMS of Ukraine», Kharkiv, Ukraine
10 shared publications - Natalia Smolienko
SI «V. Danilevsky Institute for Endocrine pathology Problems of the NAMS of Ukraine», Kharkiv, Ukraine
9 shared publications - Kateryna Misiura
SI «V. Danilevsky Institute for Endocrine pathology Problems of the NAMS of Ukraine», Kharkiv, Ukraine
8 shared publications - Nataliia Brechka
SI «V. Danilevsky Institute for Endocrine Pathology Problems of the NAMS of Ukraine», Kharkiv, Ukraine; Private establishment of higher education «Kharkiv institute of medicine and biomedical sciences», Kharkiv, Ukraine
7 shared publications
Latest Publications
- Open Access
- 14 November 2026
- Published by Publishing House Zaslavsky in INTERNATIONAL JOURNAL OF ENDOCRINOLOGY (Ukraine)
- Vol. 22 (7) , 715-722
The potential role of the SLC22A1 rs628031 A>G polymorphism in the pathogenetic mechanisms of hormonal and metabolic response to antihyperglycemic therapy
Background. Metformin is widely used as a first-line antihyperglycemic therapy in patients with type 2 diabetes mellitus (T2DM); however, individual variability in treatment response remains an important clinical issue. Genetic variations in the solute carrier family 22 member 1 (SLC22A1) gene, encoding the organic cation transporter 1 (OCT1), may influence metformin pharmacokinetics and metabolic effects. The purpose of this study was to evaluate the potential role of the SLC22A1 rs628031 A>G (Met408Val) polymorphism in the pathogenetic mechanisms of hormonal and metabolic responses to antihyperglycemic therapy in patients with T2DM and obesity. Materials and methods. The study included 61 patients with T2DM aged 28–80 years (35 men and 26 women) with metabolic syndrome and obesity (body mass index ≥ 30 kg/m2). All patients received oral antihyperglycemic therapy, including metformin, sulfonylureas, or their combinations. According to the antihyperglycemic therapy received, the patients were retrospectively divided into two groups: those receiving metformin-based therapy and those treated with other glucose-lowering agents (sulfonylureas or their combinations without metformin). Clinical, anthropometric, biochemical, hormonal, and metabolic parameters were assessed, including carbohydrate and lipid metabolism indices, liver function markers, adipokine profile, and oxidative stress parameters. Genotyping of the SLC22A1 rs628031 A>G polymorphism was performed using polymerase chain reaction and restriction fragment length polymorphism analysis with MscI restriction enzyme. Results. Metformin-based therapy was associated with favorable changes in glycemic control, lipid profile, adipokine status, and oxidative stress markers in patients with T2DM and obesity. Carriers of the AG genotype of the SLC22A1 rs628031 polymorphism receiving metformin demonstrated significantly lower levels of low-density lipoprotein cholesterol, total cholesterol, omentin, osteoprotegerin, alanine aminotransferase, and aspartate aminotransferase compared with other genotype groups. At the same time, AG genotype carriers showed higher omentin and osteoprotegerin concentrations compared with AA genotype carriers, suggesting genotype-dependent modulation of metformin-associated metabolic effects. Conclusions. The obtained results indicate that the SLC22A1 rs628031 A>G polymorphism may contribute to variability in hormonal and metabolic responses to metformin therapy in patients with T2DM and obesity. Genetic differences in OCT1 function may influence lipid metabolism, adipokine regulation, liver homeostasis, and potentially bone-related metabolic processes. Assessment of SLC22A1 genetic variants may contribute to the development of personalized approaches for optimizing antihyperglycemic therapy and improving metabolic outcomes in patients with diabetes and metabolic disorders.
- 14 November 2026
- Published by Publishing House Zaslavsky in INTERNATIONAL JOURNAL OF ENDOCRINOLOGY (Ukraine)
- Vol. 22 (7) , 715-722
Open AccessThe potential role of the SLC22A1 rs628031 A>G polymorphism in the pathogenetic mechanisms of hormonal and metabolic response to antihyperglycemic therapy
Background. Metformin is widely used as a first-line antihyperglycemic therapy in patients with type 2 diabetes mellitus (T2DM); however, individual variability in treatment response remains an important clinical issue. Genetic variations in the solute carrier family 22 member 1 (SLC22A1) gene, encoding the organic cation transporter 1 (OCT1), may influence metformin pharmacokinetics and metabolic effects. The purpose of this study was to evaluate the potential role of the SLC22A1 rs628031 A>G (Met408Val) polymorphism in the pathogenetic mechanisms of hormonal and metabolic responses to antihyperglycemic therapy in patients with T2DM and obesity. Materials and methods. The study included 61 patients with T2DM aged 28–80 years (35 men and 26 women) with metabolic syndrome and obesity (body mass index ≥ 30 kg/m2). All patients received oral antihyperglycemic therapy, including metformin, sulfonylureas, or their combinations. According to the antihyperglycemic therapy received, the patients were retrospectively divided into two groups: those receiving metformin-based therapy and those treated with other glucose-lowering agents (sulfonylureas or their combinations without metformin). Clinical, anthropometric, biochemical, hormonal, and metabolic parameters were assessed, including carbohydrate and lipid metabolism indices, liver function markers, adipokine profile, and oxidative stress parameters. Genotyping of the SLC22A1 rs628031 A>G polymorphism was performed using polymerase chain reaction and restriction fragment length polymorphism analysis with MscI restriction enzyme. Results. Metformin-based therapy was associated with favorable changes in glycemic control, lipid profile, adipokine status, and oxidative stress markers in patients with T2DM and obesity. Carriers of the AG genotype of the SLC22A1 rs628031 polymorphism receiving metformin demonstrated significantly lower levels of low-density lipoprotein cholesterol, total cholesterol, omentin, osteoprotegerin, alanine aminotransferase, and aspartate aminotransferase compared with other genotype groups. At the same time, AG genotype carriers showed higher omentin and osteoprotegerin concentrations compared with AA genotype carriers, suggesting genotype-dependent modulation of metformin-associated metabolic effects. Conclusions. The obtained results indicate that the SLC22A1 rs628031 A>G polymorphism may contribute to variability in hormonal and metabolic responses to metformin therapy in patients with T2DM and obesity. Genetic differences in OCT1 function may influence lipid metabolism, adipokine regulation, liver homeostasis, and potentially bone-related metabolic processes. Assessment of SLC22A1 genetic variants may contribute to the development of personalized approaches for optimizing antihyperglycemic therapy and improving metabolic outcomes in patients with diabetes and metabolic disorders.
- Open Access
- 2 October 2026
- Published by Publishing House Zaslavsky in INTERNATIONAL JOURNAL OF ENDOCRINOLOGY (Ukraine)
- Vol. 22 (6) , 599-604
Plasma atherogenic index as a non-invasive criterion for the diagnosis of metabolic dysfunction-associated steatotic liver disease in patients with type 2 diabetes mellitus
Background. Identification of risk factors and detection of target organs in the early stages of the formation of cardiovascular diseases, liver and kidney diseases and other complications with the correction of identified disorders is an integral part of the successful reduction of morbidity and mortality among the population. Diabetes mellitus (DM) is a syndrome of various etiologies, characterized mainly by chronic hyperglycemia with disorders associated with protein and lipid metabolism. The purpose of the study was to determine the presence and nature of the relationship of a new indirect index with the presence (or absence) of metabolically associated steatotic fatty liver disease (MASLD) in patients with T2DM, to determine the contribution of the atherogenic index of plasma (AIP) to the risk of developing liver disease and to characterize its diagnostic value using logistic regression and ROC analysis. Materials and methods. Sixty patients with T2DM were examined (33/27 men/women; age 53.00 ± 1.20 years; disease duration 13.36 ± 3.49 years), of them 24 participants with MASLD and 36 without it. The diagnosis of MASLD was established on the basis of clinical analysis of the disease, lipid and carbohydrate metabolism indicators, aspartate aminotransferase and alanine aminotransferase activity and ultrasound examination of the liver. Results. A significant and statistically significant relationship was found between the AIP and the presence of metabolically associated fatty liver disease. A distinct and significant correlation was established between the AIP and glycemia, as well as some indicators of oxidative stress (in particular, the index of free fatty acids and OXY levels) and the level of lipocalin, an adipokine. A diagnostic model was developed to identify risk groups for the development of MASLD in patients with T2DM based on the AIP. Conclusions. A diagnostic model was developed to form risk groups for MASLD among patients with T2DM using logistic regression and ROC analysis. The diagnostic criterion is a new non-invasive indicator — the AIP, the threshold value of the predictor is defined as 0.60.
- 2 October 2026
- Published by Publishing House Zaslavsky in INTERNATIONAL JOURNAL OF ENDOCRINOLOGY (Ukraine)
- Vol. 22 (6) , 599-604
Open AccessPlasma atherogenic index as a non-invasive criterion for the diagnosis of metabolic dysfunction-associated steatotic liver disease in patients with type 2 diabetes mellitus
Background. Identification of risk factors and detection of target organs in the early stages of the formation of cardiovascular diseases, liver and kidney diseases and other complications with the correction of identified disorders is an integral part of the successful reduction of morbidity and mortality among the population. Diabetes mellitus (DM) is a syndrome of various etiologies, characterized mainly by chronic hyperglycemia with disorders associated with protein and lipid metabolism. The purpose of the study was to determine the presence and nature of the relationship of a new indirect index with the presence (or absence) of metabolically associated steatotic fatty liver disease (MASLD) in patients with T2DM, to determine the contribution of the atherogenic index of plasma (AIP) to the risk of developing liver disease and to characterize its diagnostic value using logistic regression and ROC analysis. Materials and methods. Sixty patients with T2DM were examined (33/27 men/women; age 53.00 ± 1.20 years; disease duration 13.36 ± 3.49 years), of them 24 participants with MASLD and 36 without it. The diagnosis of MASLD was established on the basis of clinical analysis of the disease, lipid and carbohydrate metabolism indicators, aspartate aminotransferase and alanine aminotransferase activity and ultrasound examination of the liver. Results. A significant and statistically significant relationship was found between the AIP and the presence of metabolically associated fatty liver disease. A distinct and significant correlation was established between the AIP and glycemia, as well as some indicators of oxidative stress (in particular, the index of free fatty acids and OXY levels) and the level of lipocalin, an adipokine. A diagnostic model was developed to identify risk groups for the development of MASLD in patients with T2DM based on the AIP. Conclusions. A diagnostic model was developed to form risk groups for MASLD among patients with T2DM using logistic regression and ROC analysis. The diagnostic criterion is a new non-invasive indicator — the AIP, the threshold value of the predictor is defined as 0.60.
- 13 March 2026
- Published by European Scientific Platform (Publications)
- p. 315-317
THE USE OF VIRTUAL MICROSCOPY IN TEACHING AND LEARNING HISTOLOGY AND IN SCIENTIFIC INVESTIGATIONS IN MEDICAL EDUCATION: A GLOBAL PERSPECTIVE
Since 1670, when Antonie van Leeuwenhoek began making single-lens microscopes and used for observing various specimen’s, microscopy remained an integral part even till today. It is a cornerstone of medical education, particularly in histology and pathology.
- 13 March 2026
- Published by European Scientific Platform (Publications)
- p. 315-317
THE USE OF VIRTUAL MICROSCOPY IN TEACHING AND LEARNING HISTOLOGY AND IN SCIENTIFIC INVESTIGATIONS IN MEDICAL EDUCATION: A GLOBAL PERSPECTIVE
Since 1670, when Antonie van Leeuwenhoek began making single-lens microscopes and used for observing various specimen’s, microscopy remained an integral part even till today. It is a cornerstone of medical education, particularly in histology and pathology.
- Open Access
- 30 December 2025
- Published by Publishing House Zaslavsky in INTERNATIONAL JOURNAL OF ENDOCRINOLOGY (Ukraine)
- Vol. 21 (8) , 799-806
Adiponectin gene polymorphism +45 T>G ADIPOQ rs2241766 as one of the factors in the pharmacogenetics of type 2 diabetes mellitus
Background. Diabetes mellitus is a syndrome of various etiologies, characterized mainly by chronic hyperglycemia with disorders associated with protein and lipid metabolism. Numerous risk factors for the development of type 2 diabetes have been identified, the most important of which is the pathogenetic contribution of visceral obesity. Adipose tissue is now understood to be an active endocrine organ, secreting various hormones and cytokines that regulate metabolism and inflammation. The ADIPOQ gene located on chromosome 3q27, a region that recent scans of the entire human genome have suggested as a “type 2 diabetes susceptibility locus”, encodes the hormone adiponectin, which is derived from adipose tissue. The purpose of the study is to clarify the role of the adiponectin gene polymorphism +45 T>G ADIPOQ rs2241766 in the mechanisms of pharmacogenetic response in patients with obesity and type 2 diabetes, taking into account the assessment of its impact on the course and effectiveness of therapy. Materials and methods. Sixty-one people were selected for analysis. All patients received oral hypoglycemic drugs: sulfonamides, biguanides or their combination before hospitalization in the clinic. A comparative analysis of a number of biochemical parameters was conducted in the groups that took or did not take metformin as the main sugar-lowering drug, considering the single nucleotide polymorphism of the adiponectin gene. Results. The results indicate that the aforementioned drug has antioxidant properties, a certain hepatoprotective effect (a significant decrease in aspartate and alanine aminotransferase in G allele carriers who received the drug); also, the ability to improve the lipid profile, including in G allele carriers, has been statistically proven, that is, it has the potential to reduce the risk of developing cardiovascular complications, which is the main cause of death in patients. Conclusions. Genetic testing can be used to divide patients with type 2 diabetes and obesity into specific clusters and/or endophenotypes. Advances in the field of pharmacogenomics will allow clinicians to select personalized drug therapy regimens in order to increase its effectiveness and reduce the risk of developing adverse events.
- 30 December 2025
- Published by Publishing House Zaslavsky in INTERNATIONAL JOURNAL OF ENDOCRINOLOGY (Ukraine)
- Vol. 21 (8) , 799-806
Open AccessAdiponectin gene polymorphism +45 T>G ADIPOQ rs2241766 as one of the factors in the pharmacogenetics of type 2 diabetes mellitus
Background. Diabetes mellitus is a syndrome of various etiologies, characterized mainly by chronic hyperglycemia with disorders associated with protein and lipid metabolism. Numerous risk factors for the development of type 2 diabetes have been identified, the most important of which is the pathogenetic contribution of visceral obesity. Adipose tissue is now understood to be an active endocrine organ, secreting various hormones and cytokines that regulate metabolism and inflammation. The ADIPOQ gene located on chromosome 3q27, a region that recent scans of the entire human genome have suggested as a “type 2 diabetes susceptibility locus”, encodes the hormone adiponectin, which is derived from adipose tissue. The purpose of the study is to clarify the role of the adiponectin gene polymorphism +45 T>G ADIPOQ rs2241766 in the mechanisms of pharmacogenetic response in patients with obesity and type 2 diabetes, taking into account the assessment of its impact on the course and effectiveness of therapy. Materials and methods. Sixty-one people were selected for analysis. All patients received oral hypoglycemic drugs: sulfonamides, biguanides or their combination before hospitalization in the clinic. A comparative analysis of a number of biochemical parameters was conducted in the groups that took or did not take metformin as the main sugar-lowering drug, considering the single nucleotide polymorphism of the adiponectin gene. Results. The results indicate that the aforementioned drug has antioxidant properties, a certain hepatoprotective effect (a significant decrease in aspartate and alanine aminotransferase in G allele carriers who received the drug); also, the ability to improve the lipid profile, including in G allele carriers, has been statistically proven, that is, it has the potential to reduce the risk of developing cardiovascular complications, which is the main cause of death in patients. Conclusions. Genetic testing can be used to divide patients with type 2 diabetes and obesity into specific clusters and/or endophenotypes. Advances in the field of pharmacogenomics will allow clinicians to select personalized drug therapy regimens in order to increase its effectiveness and reduce the risk of developing adverse events.
- 11 December 2025
- Published by ALUNA in Wiadomości Lekarskie
- Vol. 2025 (10) , 1998-2007
Pathogenetic aspects of the features of androgen deficiency state under the condition of experimental varicocele
Aim: The aim of this article is to study of the main pathogenetic aspects of the features of androgen deficiency state under the condition of experimental varicocele caused by serotonin hydrochloride Material and methods: Simulation of serotonin testicular damage (experimental varicocele) is used to reproduce gonadal pathology. In the mechanism of the development of this gonadopathy was the vasoconstrictor effect of serotonin hydrochloride plays a leading role. Serotonin hydrochloride (Alfa Aesar®, USA) was administered for 14 days at a dose of 5 mg/kg of body weight (“pathology” group). Results: Experimental varicocele led to disturbance of structural elements of connective tissue (and the content of connective tissue components of glycosaminoglycans in the testes and chondroitin sulfates in the seminal plasma) as a leading link in the pathogenetic chain which promotes the formation of hormone dependent reproductive diseasess. Conclusions: Experimental varicocele on the background of the androgen deficiency state led to the disturbance of the morphofunctional state of the mitochondria of testicular cells, damage to the nuclear membrane, a decrease in the content of testosterone in the blood and fructose in the seminal vesicles; a decrease in the concentration and motility of spermatozoa.
- 11 December 2025
- Published by ALUNA in Wiadomości Lekarskie
- Vol. 2025 (10) , 1998-2007
Pathogenetic aspects of the features of androgen deficiency state under the condition of experimental varicocele
Aim: The aim of this article is to study of the main pathogenetic aspects of the features of androgen deficiency state under the condition of experimental varicocele caused by serotonin hydrochloride Material and methods: Simulation of serotonin testicular damage (experimental varicocele) is used to reproduce gonadal pathology. In the mechanism of the development of this gonadopathy was the vasoconstrictor effect of serotonin hydrochloride plays a leading role. Serotonin hydrochloride (Alfa Aesar®, USA) was administered for 14 days at a dose of 5 mg/kg of body weight (“pathology” group). Results: Experimental varicocele led to disturbance of structural elements of connective tissue (and the content of connective tissue components of glycosaminoglycans in the testes and chondroitin sulfates in the seminal plasma) as a leading link in the pathogenetic chain which promotes the formation of hormone dependent reproductive diseasess. Conclusions: Experimental varicocele on the background of the androgen deficiency state led to the disturbance of the morphofunctional state of the mitochondria of testicular cells, damage to the nuclear membrane, a decrease in the content of testosterone in the blood and fructose in the seminal vesicles; a decrease in the concentration and motility of spermatozoa.
- Open Access
- 29 September 2025
- Published by Publishing House Zaslavsky in INTERNATIONAL JOURNAL OF ENDOCRINOLOGY (Ukraine)
- Vol. 21 (6) , 619-625
The potential role of the MTHFR C677T polymorphism in the pathogenetic mechanisms of hormonal and metabolic response to antihyperglycemic therapy
Background. Type 2 diabetes mellitus (T2DM) is a multifactorial disease involving both environmental and genetic components. The methylenetetrahydrofolate reductase (MTHFR) gene, particularly the C677T polymorphism, influences folate metabolism and homocysteine levels and may affect metabolic processes and pharmacological response. Metformin is the first-line antihyperglycemic agent for T2DM, but interindividual variability in treatment response remains a key issue. The purpose of the work is to identify and assess the potential impact of a pathogenetically significant single-nucleotide polymorphism of the MTHFR gene on the development of obesity and type 2 diabetes mellitus in the implementation of the hormonal and metabolic effects of pharmacological factors. Materials and methods. This study included 28 patients with T2DM and metabolic syndrome (body mass index ≥ 30 kg/m2). Clinical, biochemical, and anthropometric parameters were assessed. Genotyping of the MTHFR C677T polymorphism was performed using polymerase chain reaction and restriction fragment length polymorphism. The effects of metformin therapy were evaluated by analyzing glycemic control, lipid profile, liver function, adipokine levels, and oxidative stress markers, taking into account the patients’ MTHFR genotypes. Results. Metformin use was associated with improved lipid profile in all genotypes. In addition, a genotype-specific reduction in liver enzyme activity was observed: aspartate aminotransferase levels decreased significantly in T allele carriers, while alanine aminotransferase reduced in patients with the CC genotype. These results suggest both pleiotropic and genotype-dependent hepatoprotective effects of metformin. No significant differences in MTHFR genotype distribution were found between metformin-treated and untreated groups. Conclusions. Metformin has beneficial metabolic effects in T2DM patients and may exert genotype-specific hepatoprotective properties. The C677T polymorphism of the MTHFR gene did not determine whether patients were prescribed metformin, but it may modulate liver-related biochemical responses to the drug. These findings support the relevance of pharmacogenetic approaches to optimize therapy in T2DM.
- 29 September 2025
- Published by Publishing House Zaslavsky in INTERNATIONAL JOURNAL OF ENDOCRINOLOGY (Ukraine)
- Vol. 21 (6) , 619-625
Open AccessThe potential role of the MTHFR C677T polymorphism in the pathogenetic mechanisms of hormonal and metabolic response to antihyperglycemic therapy
Background. Type 2 diabetes mellitus (T2DM) is a multifactorial disease involving both environmental and genetic components. The methylenetetrahydrofolate reductase (MTHFR) gene, particularly the C677T polymorphism, influences folate metabolism and homocysteine levels and may affect metabolic processes and pharmacological response. Metformin is the first-line antihyperglycemic agent for T2DM, but interindividual variability in treatment response remains a key issue. The purpose of the work is to identify and assess the potential impact of a pathogenetically significant single-nucleotide polymorphism of the MTHFR gene on the development of obesity and type 2 diabetes mellitus in the implementation of the hormonal and metabolic effects of pharmacological factors. Materials and methods. This study included 28 patients with T2DM and metabolic syndrome (body mass index ≥ 30 kg/m2). Clinical, biochemical, and anthropometric parameters were assessed. Genotyping of the MTHFR C677T polymorphism was performed using polymerase chain reaction and restriction fragment length polymorphism. The effects of metformin therapy were evaluated by analyzing glycemic control, lipid profile, liver function, adipokine levels, and oxidative stress markers, taking into account the patients’ MTHFR genotypes. Results. Metformin use was associated with improved lipid profile in all genotypes. In addition, a genotype-specific reduction in liver enzyme activity was observed: aspartate aminotransferase levels decreased significantly in T allele carriers, while alanine aminotransferase reduced in patients with the CC genotype. These results suggest both pleiotropic and genotype-dependent hepatoprotective effects of metformin. No significant differences in MTHFR genotype distribution were found between metformin-treated and untreated groups. Conclusions. Metformin has beneficial metabolic effects in T2DM patients and may exert genotype-specific hepatoprotective properties. The C677T polymorphism of the MTHFR gene did not determine whether patients were prescribed metformin, but it may modulate liver-related biochemical responses to the drug. These findings support the relevance of pharmacogenetic approaches to optimize therapy in T2DM.
- Open Access
- 15 September 2025
- Published by V.Danilevsky Institute for Endocrine Pathology Problems of NAMSU in PROBLEMS OF ENDOCRINE PATHOLOGY
- Vol. 82 (3) , 20-28
VITAMIN D AND SAW PALMETTO FRUIT EXTRACT IN EXPERIMENTAL PROSTATE PATHOLOGY
Benign prostatic hyperplasia is a serious problem that significantly reduces the quality of life of men, so the search for new prostatoprotectors is highly relevant.The aim: to evaluate the effect of vitamin D and saw palmetto fruit extract on prostate mass, sex hormone levels, and sexual behavior under experimental conditions of prostate pathology.Materials and methods. Prostate pathology was induced by administration of sulpiride solution at a dose of 40 mg/kg b.w. to 12-month-old male rats for 30 days (BPH group). For correction, the following treatments were administered for 21 days per os: vitamin D3 at a dose of 4000 IU (BPH+vit.D group); Sabal palm fruit extract at a dose of 35 mg/kg b.w. (BPH+Ref group); or vitamin D3 and Sabal palm fruit extract at the same doses (BPH+vit.D+Ref group) were administered together. Sexual behavior, genital organ mass, and serum testosterone (T) and estradiol (E2) levels were determined. The probability of differences in mean values was determined by Student's t test. The χ2 test was used for comparative analysis of relative values. Differences were considered significant at p < 0.05.Results. In the BPH group, the prostate mass increased, and in the BPH+Vit.D+Ref group, the organ mass normalized. Serum total T levels in the BPH group decreased by 1.66 times, and the T/E2 ratio was 1.53 times lower than in the control group. When using corrective substances, the T concentration normalized. The T/E2 ratio increased by 1.5 times. In the BPH group, both the courtship and copulatory components of sexual behavior were impaired, and no male in this group ejaculated. In the BPH+Ref group, the latency period for the onset of mounts (by 2.7 times) and intromissions (by 1.7 times) decreased, the number of courtship behaviors decreased by 1.9 times, compared to the BPH group. In animals in the BPH+vit.D+Ref group, the latency period for mounts decreased by 3.3 times, intromissions - by 4.4 times, the number of mounts and intromissions increased by 2.2 and 2.9 times compared to the BPH group. Ejaculations were recorded in 40% of males in this group.Conclusions. Experimental sulpiride-induced prostatic hyperplasia is accompanied by an increase in the mass of prostate, an imbalance of hormonal ratios, and suppression of sexual behavior parameters. The combined use of vitamin D and saw palmetto fruit extract corrects BPH, promotes normalization of prostate mass, an increase in testosterone levels, and restores the ratio of sex hormones, and improves both the courtship and copulatory components of the sexual behavior in rats.
- 15 September 2025
- Published by V.Danilevsky Institute for Endocrine Pathology Problems of NAMSU in PROBLEMS OF ENDOCRINE PATHOLOGY
- Vol. 82 (3) , 20-28
Open AccessVITAMIN D AND SAW PALMETTO FRUIT EXTRACT IN EXPERIMENTAL PROSTATE PATHOLOGY
Benign prostatic hyperplasia is a serious problem that significantly reduces the quality of life of men, so the search for new prostatoprotectors is highly relevant.The aim: to evaluate the effect of vitamin D and saw palmetto fruit extract on prostate mass, sex hormone levels, and sexual behavior under experimental conditions of prostate pathology.Materials and methods. Prostate pathology was induced by administration of sulpiride solution at a dose of 40 mg/kg b.w. to 12-month-old male rats for 30 days (BPH group). For correction, the following treatments were administered for 21 days per os: vitamin D3 at a dose of 4000 IU (BPH+vit.D group); Sabal palm fruit extract at a dose of 35 mg/kg b.w. (BPH+Ref group); or vitamin D3 and Sabal palm fruit extract at the same doses (BPH+vit.D+Ref group) were administered together. Sexual behavior, genital organ mass, and serum testosterone (T) and estradiol (E2) levels were determined. The probability of differences in mean values was determined by Student's t test. The χ2 test was used for comparative analysis of relative values. Differences were considered significant at p < 0.05.Results. In the BPH group, the prostate mass increased, and in the BPH+Vit.D+Ref group, the organ mass normalized. Serum total T levels in the BPH group decreased by 1.66 times, and the T/E2 ratio was 1.53 times lower than in the control group. When using corrective substances, the T concentration normalized. The T/E2 ratio increased by 1.5 times. In the BPH group, both the courtship and copulatory components of sexual behavior were impaired, and no male in this group ejaculated. In the BPH+Ref group, the latency period for the onset of mounts (by 2.7 times) and intromissions (by 1.7 times) decreased, the number of courtship behaviors decreased by 1.9 times, compared to the BPH group. In animals in the BPH+vit.D+Ref group, the latency period for mounts decreased by 3.3 times, intromissions - by 4.4 times, the number of mounts and intromissions increased by 2.2 and 2.9 times compared to the BPH group. Ejaculations were recorded in 40% of males in this group.Conclusions. Experimental sulpiride-induced prostatic hyperplasia is accompanied by an increase in the mass of prostate, an imbalance of hormonal ratios, and suppression of sexual behavior parameters. The combined use of vitamin D and saw palmetto fruit extract corrects BPH, promotes normalization of prostate mass, an increase in testosterone levels, and restores the ratio of sex hormones, and improves both the courtship and copulatory components of the sexual behavior in rats.
- Open Access
- 9 May 2025
- Published by European Scientific Platform (Publications)
- No. May 9, 202,p. 241-244
ADVANTAGES OF USING BUCCAL FAT-DERIVED STEM CELLS IN REPRODUCTIVE MEDICINE
Introduction. Buccal fat-derived stem cells (BFSCs) haven’t traditionally been linked to reproductive medicine, but they hold emerging potential due to their mesenchymal stem cell (MSC) nature. Here's how researchers are starting to look at them from a reproductive medicine perspective:
- 9 May 2025
- Published by European Scientific Platform (Publications)
- No. May 9, 202,p. 241-244
Open AccessADVANTAGES OF USING BUCCAL FAT-DERIVED STEM CELLS IN REPRODUCTIVE MEDICINE
Introduction. Buccal fat-derived stem cells (BFSCs) haven’t traditionally been linked to reproductive medicine, but they hold emerging potential due to their mesenchymal stem cell (MSC) nature. Here's how researchers are starting to look at them from a reproductive medicine perspective:
- 30 March 2025
- Published by Scienceline Publication in World's Veterinary Journal
- Vol. 15 (1) , 167-175
Oxidative Stress Markers, Antioxidant Balance, and Protein Metabolism in Dogs with Acute Prostatitis
The prostate gland in dogs is highly vulnerable to the action of negative pathogens due to its structure and topography. Among the numerous etiological factors in the development of prostatitis, inflammatory processes and oxidative stress play a predominant role, regardless of whether the condition is bacterial, viral, or autoimmune in origin. This study aimed to assess protein metabolism and redox balance indicators in the prostate tissue of dogs with acute prostatitis. For biochemical analyses, prostate tissue samples were taken from 24 mixed-breed dogs, including twelve animals that were considered healthy with no abnormalities of the genitourinary system (control group) and twelve animals with newly diagnosed acute prostatitis, from which samples were obtained via biopsy (experimental group). Following homogenization and sample preparation, all biochemical parameters in the prostate tissue were determined spectrophotometrically. The results of biochemical studies in dogs with acute prostatitis demonstrated a significant increase in the content of thiobarbiturate acid-reactive compounds by 102.2% and the level of lipid hydroperoxides by 35.7% compared to healthy dogs in the control group. In contrast, the total protein content was 32.9% lower than in the control group, while reduced glutathione levels decreased by 76.5%. Similar changes to the dynamics of oxidative stress markers were indicated by the activity of antioxidant enzymes, with glutathione peroxidase and catalase activities increasing by 61.3% and 21.8%, respectively, relative to the control group. These findings indicate the presence of oxidative stress in dogs with acute prostatitis. The biochemical changes observed in prostate tissue provide a foundation for future research aimed at developing therapeutic methods that incorporate anti-inflammatory, antibacterial, and antioxidant agents for the treatment of acute prostatitis in dogs.
- 30 March 2025
- Published by Scienceline Publication in World's Veterinary Journal
- Vol. 15 (1) , 167-175
Oxidative Stress Markers, Antioxidant Balance, and Protein Metabolism in Dogs with Acute Prostatitis
The prostate gland in dogs is highly vulnerable to the action of negative pathogens due to its structure and topography. Among the numerous etiological factors in the development of prostatitis, inflammatory processes and oxidative stress play a predominant role, regardless of whether the condition is bacterial, viral, or autoimmune in origin. This study aimed to assess protein metabolism and redox balance indicators in the prostate tissue of dogs with acute prostatitis. For biochemical analyses, prostate tissue samples were taken from 24 mixed-breed dogs, including twelve animals that were considered healthy with no abnormalities of the genitourinary system (control group) and twelve animals with newly diagnosed acute prostatitis, from which samples were obtained via biopsy (experimental group). Following homogenization and sample preparation, all biochemical parameters in the prostate tissue were determined spectrophotometrically. The results of biochemical studies in dogs with acute prostatitis demonstrated a significant increase in the content of thiobarbiturate acid-reactive compounds by 102.2% and the level of lipid hydroperoxides by 35.7% compared to healthy dogs in the control group. In contrast, the total protein content was 32.9% lower than in the control group, while reduced glutathione levels decreased by 76.5%. Similar changes to the dynamics of oxidative stress markers were indicated by the activity of antioxidant enzymes, with glutathione peroxidase and catalase activities increasing by 61.3% and 21.8%, respectively, relative to the control group. These findings indicate the presence of oxidative stress in dogs with acute prostatitis. The biochemical changes observed in prostate tissue provide a foundation for future research aimed at developing therapeutic methods that incorporate anti-inflammatory, antibacterial, and antioxidant agents for the treatment of acute prostatitis in dogs.
- Open Access
- 15 March 2025
- Published by V.Danilevsky Institute for Endocrine Pathology Problems of NAMSU in PROBLEMS OF ENDOCRINE PATHOLOGY
- Vol. 82 (1) , 50-57
THE IMPACT OF VITAMIN D AND/OR SAW PALMETTA BERRY EXTRACT ON THE SPERMOGRAMM AND SPERMATOZOA FUNCTIONING UNDER THE CONDITION OF EXPERIMENTAL BENIGN PROSTATIC HYPERPLASIA
The tendency to the declining of number of spermatozoa in the ejaculate is detected in men worldwide. Benign prostatic hyperplasia (BPH) is one of the common pathology of men urogenital system. The infertility can be the consequence of this pathology. The significant number of side effects occurred during BHP medication encourages the development of new remedies for BHP prophylaxis and therapy. The laboratory animals are used in the experimental medicine with the aim to design pathological conditions. The Sulpiride model is often used for investigation of prostate gland protective activity of medicines in rats. This model’ essence lies in the prolonged sulpiride introduction which induces BPH development. The experimental and clinical investigations demonstrate questionable data as for vitamin D influence on the spermogram parameters. Purpose. To determine the efficacy of cholecalciferol (vitamin D) administration, separately or together with Saw Palmetta berry extract, as for correction of spermogram in rats males under the condition of experimental sulpiride-induced benign prostatic hyperplasia. Materials and methods. BPH has been modeled by intramuscular introduction of Sulpiride in dose of 40 mg/kg to 12-month rat males with body mass of 330-380 g during 30 days. The correction of BPH was carried out by vitamin D3 in dose of 4000 IU or saw Palmetta berry extract in dose of 35 mg/kg, separately or together, during 21 days after last injection of Sulpiride. Control group of animals have simultaneously received injection of Sulpiride and 0,9% solution of Sodium Chloride in dose of 0.5 mL. The spermatogenesis (sperms concentration, the percentage of motile and dead cells) and functional capacity of gametes have been evaluated in the suspension of spermatozoa obtained from epididymides of decapitated males. The probability of mean deviation has been determined according to t-Student test. Data were performed as arithmetic mean () and standard error of the mean (±S). The differences were considered to be significant at Р<0.05. Results. It has been determined that Sulpiride-induced BPH has caused statistically significant changes of all spermogram’ parameters which appears in the declined concentration and motility of gametes, in the increased number of pathological and dead forms of sperms comparing to Control group. The correction of spermatogenesis disturbances by cholecalciferol or reference medicine has led to statistically significant increase in motile sperms percentage almost by two times and to the decrease in number of dead cells almost by two times in rats with BPH comparing to nontreated BPH group. Simultaneous use of vitamin D3 with reference medicine has caused the increasing by 1.7 times of sperms motility, gametes concentration by 1.5 times, the concentration of morphologically normal cells by 1.6 times and decreasing of number of dead cells almost two times in rats with experimental pathology comparing to BPH group. Conclusions. Sulpiride-induced benign prostatic hyperplasia causes the disturbance of spermatogenesis and functional capacity of spermatozoa in 12-month rat males. The correction of this pathology by cholecalciferol has improved sperm cells motility and has declined the percentage of dead cells. The same effect has been observed after administration of Saw Palmetta Berry extract. Simultaneous administration of these medicines has increased spermatozoa concentration, the number of morphologically normal gametes, sperms motility and has declined the percentage of dead sperm cells in rats with experimental benign prostatic hyperplasia.
- 15 March 2025
- Published by V.Danilevsky Institute for Endocrine Pathology Problems of NAMSU in PROBLEMS OF ENDOCRINE PATHOLOGY
- Vol. 82 (1) , 50-57
Open AccessTHE IMPACT OF VITAMIN D AND/OR SAW PALMETTA BERRY EXTRACT ON THE SPERMOGRAMM AND SPERMATOZOA FUNCTIONING UNDER THE CONDITION OF EXPERIMENTAL BENIGN PROSTATIC HYPERPLASIA
The tendency to the declining of number of spermatozoa in the ejaculate is detected in men worldwide. Benign prostatic hyperplasia (BPH) is one of the common pathology of men urogenital system. The infertility can be the consequence of this pathology. The significant number of side effects occurred during BHP medication encourages the development of new remedies for BHP prophylaxis and therapy. The laboratory animals are used in the experimental medicine with the aim to design pathological conditions. The Sulpiride model is often used for investigation of prostate gland protective activity of medicines in rats. This model’ essence lies in the prolonged sulpiride introduction which induces BPH development. The experimental and clinical investigations demonstrate questionable data as for vitamin D influence on the spermogram parameters. Purpose. To determine the efficacy of cholecalciferol (vitamin D) administration, separately or together with Saw Palmetta berry extract, as for correction of spermogram in rats males under the condition of experimental sulpiride-induced benign prostatic hyperplasia. Materials and methods. BPH has been modeled by intramuscular introduction of Sulpiride in dose of 40 mg/kg to 12-month rat males with body mass of 330-380 g during 30 days. The correction of BPH was carried out by vitamin D3 in dose of 4000 IU or saw Palmetta berry extract in dose of 35 mg/kg, separately or together, during 21 days after last injection of Sulpiride. Control group of animals have simultaneously received injection of Sulpiride and 0,9% solution of Sodium Chloride in dose of 0.5 mL. The spermatogenesis (sperms concentration, the percentage of motile and dead cells) and functional capacity of gametes have been evaluated in the suspension of spermatozoa obtained from epididymides of decapitated males. The probability of mean deviation has been determined according to t-Student test. Data were performed as arithmetic mean () and standard error of the mean (±S). The differences were considered to be significant at Р<0.05. Results. It has been determined that Sulpiride-induced BPH has caused statistically significant changes of all spermogram’ parameters which appears in the declined concentration and motility of gametes, in the increased number of pathological and dead forms of sperms comparing to Control group. The correction of spermatogenesis disturbances by cholecalciferol or reference medicine has led to statistically significant increase in motile sperms percentage almost by two times and to the decrease in number of dead cells almost by two times in rats with BPH comparing to nontreated BPH group. Simultaneous use of vitamin D3 with reference medicine has caused the increasing by 1.7 times of sperms motility, gametes concentration by 1.5 times, the concentration of morphologically normal cells by 1.6 times and decreasing of number of dead cells almost two times in rats with experimental pathology comparing to BPH group. Conclusions. Sulpiride-induced benign prostatic hyperplasia causes the disturbance of spermatogenesis and functional capacity of spermatozoa in 12-month rat males. The correction of this pathology by cholecalciferol has improved sperm cells motility and has declined the percentage of dead cells. The same effect has been observed after administration of Saw Palmetta Berry extract. Simultaneous administration of these medicines has increased spermatozoa concentration, the number of morphologically normal gametes, sperms motility and has declined the percentage of dead sperm cells in rats with experimental benign prostatic hyperplasia.